title: PHARMAC and erythropoietin for cancer patients.
authors.forename: Rachel
authors.initials: R
authors.lastname: Grocott
authors.forename: Scott
authors.initials: S
authors.lastname: Metcalfe
authors.forename: Peter
authors.initials: P
authors.lastname: Moodie
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D003362:Cost-Benefit Analysis; D004335:Drug and Narcotic Control; D004921:Erythropoietin / Q000191:economics* / Q000627:therapeutic use*; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D009313:National Health Programs / Q000191:economics; D009369:Neoplasms / Q000150:complications*; D009520:New Zealand; D016896:Treatment Outcome
chemical_list: D004921:Erythropoietin